ASTELLAS PHARMA A/S: Financial statements 2020
CVR: 10888638
Source: annual report 2020, Danish Business Authority
01/04/2019 – 31/03/2020
ASTELLAS PHARMA A/S (CVR 10888638) has filed annual accounts for 2020. In 2020, the company reported revenue of EUR 187,005,000 and a net result of EUR 2,036,000 compared with EUR 4,735,000 the year before. That is an increase of 2.4% compared with the year before. The profit margin was 1.1%. Equity in the 2020 report amounted to EUR 53,572,000. The solvency ratio was 42.2%. The company had 114 employees in the financial year.
- Revenue
- EUR 187,005,000
- Gross Profit
- EUR 23,843,000
- Profit/Loss
- EUR 2,036,000
- Equity
- EUR 53,572,000
- Total Assets
- EUR 126,991,000
- Employees
- 114
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 187M EUR | 23.8M EUR | 2M EUR | 53.6M EUR | 114 |
| 2019 | 182.6M EUR | 25M EUR | 4.7M EUR | 56.2M EUR | 116 |
| 2018 | 157.8M EUR | 20.5M EUR | 2.6M EUR | 54.1M EUR | 115 |
| 2017 | 144.9M EUR | 17.9M EUR | 12.2M EUR | 51.5M EUR | 117 |
| 2016 | 156M EUR | - | 6.7M EUR | 45.4M EUR | 118 |
Official annual report
How creditworthy is ASTELLAS PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of June 30, 2020, Yagnaram Santharam has joined the board of directors of ASTELLAS PHARMA A/S.
As of June 30, 2020, Pedro Møllebro has left the board of directors of ASTELLAS PHARMA A/S.
About ASTELLAS PHARMA A/S
ASTELLAS PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1987. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named YAMANOUCHI PHARMA A/S and BROCADES PHARMA A/S. The management consists of Mark Andree Dekker. The board consists of Damla Ebru Atilgan (chair), Anne Nymand, Giuseppe Maduri and Mark Andree Dekker. The company is owned by Astellas Pharma Europe LTD.. The company has 67 employees (2026). In 2026, the company reported revenue of EUR 197,863,000 and a net result of EUR 5,229,000 compared with EUR 5,705,000 the year before. Equity in the 2026 report amounted to EUR 20,071,000.